These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17118480)

  • 21. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians.
    Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
    Hum Genet; 2000 Aug; 107(2):138-44. PubMed ID: 11030411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53).
    Gloyn AL; Hashim Y; Ashcroft SJ; Ashfield R; Wiltshire S; Turner RC;
    Diabet Med; 2001 Mar; 18(3):206-12. PubMed ID: 11318841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):317-21. PubMed ID: 17516295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
    Rissanen J; Markkanen A; Kärkkäinen P; Pihlajamäki J; Kekäläinen P; Mykkänen L; Kuusisto J; Karhapää P; Niskanen L; Laakso M
    Diabetes Care; 2000 Jan; 23(1):70-3. PubMed ID: 10857971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia.
    Goksel DL; Fischbach K; Duggirala R; Mitchell BD; Aguilar-Bryan L; Blangero J; Stern MP; O'Connell P
    Hum Genet; 1998 Sep; 103(3):280-5. PubMed ID: 9799081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Kahn SE; Franks PW; Dabelea D; Hamman RF; Knowler WC; Nathan DM; Altshuler D
    Diabetes; 2007 Feb; 56(2):531-6. PubMed ID: 17259403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
    N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects.
    Reis AF; Hani EH; Beressi N; Robert JJ; Bresson JL; Froguel P; Velho G
    Diabetes Metab; 2002 Jun; 28(3):209-15. PubMed ID: 12149601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ATP-sensitive potassium channel--sulfonylurea receptor].
    Yamada Y; Sunaga Y
    Nihon Rinsho; 1997 Oct; 55 Suppl():458-62. PubMed ID: 9392149
    [No Abstract]   [Full Text] [Related]  

  • 30. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
    Hansen T; Echwald SM; Hansen L; Møller AM; Almind K; Clausen JO; Urhammer SA; Inoue H; Ferrer J; Bryan J; Aguilar-Bryan L; Permutt MA; Pedersen O
    Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characterization of polymorphisms in the sulphonylurea receptor 1 gene in Japanese subjects with Type 2 diabetes mellitus.
    Ishiyama-Shigemoto S; Yamada K; Yuan X; Koyama W; Nonaka K
    Diabet Med; 1998 Oct; 15(10):826-9. PubMed ID: 9796882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.
    Nielsen LB; Ploug KB; Swift P; Ørskov C; Jansen-Olesen I; Chiarelli F; Holst JJ; Hougaard P; Pörksen S; Holl R; de Beaufort C; Gammeltoft S; Rorsman P; Mortensen HB; Hansen L;
    Eur J Endocrinol; 2007 Jun; 156(6):663-71. PubMed ID: 17535866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of adiponectin (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with Type 2 Diabetes in North Indian population of Punjab.
    Matharoo K; Arora P; Bhanwer AJ
    Gene; 2013 Sep; 527(1):228-34. PubMed ID: 23764562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated type 2 diabetic patients.
    Ragia G; Tavridou A; Petridis I; Manolopoulos VG
    Diabetes Res Clin Pract; 2012 Oct; 98(1):119-24. PubMed ID: 22591706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paediatric diabetes--which children can gain insulin independence?
    Srinivasan S; Donaghue KC
    Med J Aust; 2007 May; 186(9):436-7. PubMed ID: 17484702
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
    Hart LM; Dekker JM; van Haeften TW; Ruige JB; Stehouwer CD; Erkelens DW; Heine RJ; Maassen JA
    Diabetologia; 2000 Apr; 43(4):515-9. PubMed ID: 10819247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study.
    Laukkanen O; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6286-90. PubMed ID: 15579791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes.
    Li Q; Tang TT; Jiang F; Zhang R; Chen M; Yin J; Bao YQ; Cheng X; Hu C; Jia WP
    Acta Pharmacol Sin; 2017 Jan; 38(1):80-89. PubMed ID: 27694910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes.
    Holstein JD; Kovacs P; Patzer O; Stumvoll M; Holstein A
    Pharmacogenomics; 2012 Jan; 13(1):5-7; author reply 9-10. PubMed ID: 22176616
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterozygous ABCC8 mutations are a cause of MODY.
    Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
    Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.